Qlaris Bio, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Qlaris Bio, Inc.
RECRUITINGPhase 2 / Phase 3NCT07354516
Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
Firecrest study is evaluating the intraocular pressure (IOP)-lowering effect, safety, and tolerability of Qlaris' preservative free \[PF\], fixed-dose combination \[FDC\]...
Sponsor: Qlaris Bio, Inc.Enrolling: 601 location
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
RECRUITINGPhase 2NCT07354477
Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
Sponsor: Qlaris Bio, Inc.Enrolling: 141 location
Non-proliferative Diabetic Retinopathy (NPDR)Open-angle Glaucoma (OAG)Normal Tension Glaucoma (NTG)